ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 147 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is 2.13 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $415,000 | +406.1% | 77,468 | +436.1% | 0.01% | +450.0% |
| Q3 2016 | $82,000 | -26.1% | 14,451 | -28.5% | 0.00% | 0.0% |
| Q2 2016 | $111,000 | -50.7% | 20,219 | -33.1% | 0.00% | -50.0% |
| Q1 2016 | $225,000 | -42.3% | 30,212 | -35.7% | 0.00% | 0.0% |
| Q4 2015 | $390,000 | +7.4% | 46,975 | +16.3% | 0.00% | +33.3% |
| Q3 2015 | $363,000 | -73.5% | 40,379 | -64.7% | 0.00% | -75.0% |
| Q2 2015 | $1,372,000 | +28.2% | 114,335 | +15.1% | 0.01% | +20.0% |
| Q1 2015 | $1,070,000 | +81.7% | 99,313 | -14.5% | 0.01% | +150.0% |
| Q4 2014 | $589,000 | +131.0% | 116,183 | +19.9% | 0.00% | +300.0% |
| Q3 2014 | $255,000 | -25.7% | 96,874 | +14.0% | 0.00% | -50.0% |
| Q2 2014 | $343,000 | -11.8% | 85,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $389,000 | – | 85,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 15,151,516 | $38,182,000 | 7.99% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 10,406,850 | $26,225,000 | 4.02% |
| MILLER VALUE PARTNERS, LLC | 12,385,586 | $31,211,000 | 1.12% |
| CHIRON CAPITAL MANAGEMENT, LLC | 201,470 | $508,000 | 0.41% |
| Sargent Investment Group, LLC | 289,025 | $728,000 | 0.26% |
| MAGNOLIA CAPITAL ADVISORS LLC | 80,542 | $404,000 | 0.16% |
| XTX MARKETS LLC | 11,086 | $28,000 | 0.14% |
| Virtus ETF Advisers LLC | 99,108 | $250,000 | 0.13% |
| Old West Investment Management, LLC | 210,226 | $529,000 | 0.12% |
| EQUITEC PROPRIETARY MARKETS, LLC | 31,300 | $79,000 | 0.06% |